COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,314 Articles (22,772 medRxiv, 8,542 bioRxiv)

Most recent first Previous |  Page 499: Articles 4981-4990  | Next

Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up
Gram, M. A., Steenhard, N., Cohen, A. S., Vangsted, A.-M., Molbak, K., Jensen, T. G., Hansen, C. H., Ethelberg, S.
10.1101/2023.02.06.23285556 — Posted: 2023-02-08
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
Bodansky, A., Wang, C.-Y., Saxena, A., Mitchell, A., Takahashi, S., Anglin, K., Huang, B., Hoh, R., Lu, S., Goldberg, S. A., Romero, J., Tran, B., Kirtikar, R., Grebe, H., So, M., Greenhouse, B., Durstenfeld, M. S., Hsue, P. Y., Hellmuth, J., Kelly, J. D., Martin, J. N., Anderson, M. S., Deeks, S. G., Henrich, T. J., DeRisi, J. L., Peluso, M. J.
10.1101/2023.02.06.23285532 — Posted: 2023-02-08
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of oral RP7214, a DHODH inhibitor, in Patients with Symptomatic Mild SARS-CoV-2 Infection
Nair, A., Barde, P., Routhu, K. V., Vakkalanka, S., RP7214-2101 Study Group Investigator Authors (India)
10.1101/2023.02.08.23285565 — Posted: 2023-02-08
Mental distress among Norwegian adults during the Covid-19 pandemic: predictors of initial response and subsequent trajectories
Lu, L., Hannigan, L. J., Brandlistuen, R. E., Nesvag, R., Trogstad, L., Magnus, P., Unnarsdottir, A. B., Valdimarsdottir, U. A., Andreassen, O. A., Ask, H.
10.1101/2023.02.06.23285436 — Posted: 2023-02-08
Who Wears the Face Mask? Preventive Measures Against COVID-19 in Latin America Before Vaccination
Renteria, E., Gomez-Casillas, A., Zueras, P.
10.1101/2023.02.07.23285570 — Posted: 2023-02-08
Time series analysis of routine immunisation coverage during the COVID-19 pandemic in 2021 shows continued global decline and increases in Zero Dose children
Evans, B., Keiser, O., Kaiser, L., Jombart, T.
10.1101/2023.02.06.23285411 — Posted: 2023-02-08
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022
Varkila, M., Montez-Rath, M., Salomon, J., Yu, X., Block, G., Owens, D., Chertow, G., Parsonnet, J., Anand, S.
10.1101/2023.02.06.23285542 — Posted: 2023-02-08
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
Beisenova, A., Adi, W., Bashar, S. J., Velmurugan, M., Germanson, K. B., Shelef, M. A., Yesilkoy, F.
10.1101/2023.02.06.23285535 — Posted: 2023-02-08
Characteristics of COVID-19 in children and potential risk factors for requiring mechanical ventilation; an analysis of 22,490 cases from the United States
Verma, R., Ramphul, K., Lohana, P., Sombans, S., Ramphul, Y., Pekyi-Boateng, P. K. K.
10.1101/2023.02.06.23285543 — Posted: 2023-02-08
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
Wang, X., Jiang, S., Jiang, S., Li, X., Ai, J., Lin, K., Lv, S., Zhang, S., Li, M., He, X., Li, D., Li, C., Zhao, C., Zhao, X., Qiao, R., Cui, Y., Chen, Y., Li, J., Cai, G., Li, J., Dai, L., Hu, Z., Zhang, W., Zhang, Y., Wang, P.
10.1101/2023.02.07.527406 — Posted: 2023-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).